Subscribe to RSS
DOI: 10.1055/a-2788-1132
Surgical Options in Heart Failure
Authors
Abstract
Heart failure (HF) continues to be a leading cause of morbidity and mortality. Despite optimized medical therapy (OMT), a significant portion of patients will progress to advanced stages of HF to which OMT is no longer sufficient. Myocardial revascularization remains a cornerstone for patients with ischemic cardiomyopathy, with evidence showing significant survival benefits over OMT alone. Valvular interventions address secondary mitral and aortic disease that contribute to declining cardiac function. For patients with end-stage failure or cardiogenic shock, mechanical circulatory support devices and ventricular-assist devices serve as bridge or destination therapy.
Keywords
heart failure - myocardial revascularization - ischemic cardiomyopathy - mechanical circulatory support - left ventricular remodeling - surgical outcomesPublication History
Received: 12 January 2026
Accepted: 13 January 2026
Article published online:
02 February 2026
© 2026. International College of Angiology. This article is published by Thieme.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Bozkurt B, Ahmad T, Alexander KM. et al; Writing Committee Members. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail 2023; 29 (10) 1412-1451
- 2 Chioncel O, Seferovic PM, Anker SD. et al. Epidemiology of heart failure in patients with preserved, mid-range, and reduced ejection fraction: a prospective analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2020; 22 (08) 1386-1398
- 3 Del Buono MG, Moroni F, Montone RA, Azzalini L, Sanna T, Abbate A. Ischemic cardiomyopathy and heart failure after acute myocardial infarction. Curr Cardiol Rep 2022; 24 (10) 1505-1515
- 4 Petrie MC, Jhund PS, She L. et al; STICH Trial Investigators. Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). Circulation 2016; 134 (18) 1314-1324
- 5 Marui A, Nishiwaki N, Komiya T. et al; CREDO-Kyoto CABG Registry Cohort-2 Investigators. Comparison of 5-year outcomes after coronary artery bypass grafting in heart failure patients with versus without preserved left ventricular ejection fraction (from the CREDO-Kyoto CABG Registry Cohort-2). Am J Cardiol 2015; 116 (04) 580-586
- 6 Wrobel K, Stevens SR, Jones RH. et al. Influence of baseline characteristics, operative conduct, and postoperative course on 30-day outcomes of coronary artery bypass grafting among patients with left ventricular dysfunction: results from the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Circulation 2015; 132 (08) 720-730
- 7 Lawton JS, Tamis-Holland JE, Bangalore S. et al; Writing Committee Members. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022; 79 (02) e21-e129
- 8 Gaudino M, Tondi P, Benedetto U. et al. Radial artery as a coronary artery bypass conduit: 20-year results. J Am Coll Cardiol 2016; 68 (06) 603-610
- 9 Gaudino M, Taggart D, Suma H, Puskas JD, Crea F, Massetti M. The choice of conduits in coronary artery bypass surgery. J Am Coll Cardiol 2015; 66 (15) 1729-1737
- 10 Goldman S, Zadina K, Moritz T. et al; VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004; 44 (11) 2149-2156
- 11 Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004; 77 (01) 93-101
- 12 Urso S, Nogales E, González JM. et al. Bilateral internal thoracic artery versus single internal thoracic artery: a meta-analysis of propensity score-matched observational studies. Interact Cardiovasc Thorac Surg 2019; 29 (02) 163-172
- 13 Harskamp RE, Alexander JH, Ferguson Jr TB. et al. Frequency and predictors of internal mammary artery graft failure and subsequent clinical outcomes: insights from the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. Circulation 2016; 133 (02) 131-138
- 14 Gaudino M, Antoniades C, Benedetto U. et al; ATLANTIC (Arterial Grafting International Consortium) Alliance. Mechanisms, consequences, and prevention of coronary graft failure. Circulation 2017; 136 (18) 1749-1764
- 15 Neumann FJ, Sousa-Uva M, Ahlsson A. et al; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40 (02) 87-165
- 16 Verberkmoes NJ, Wolters SL, Post JC, Soliman-Hamad MA, ter Woorst JF, Berreklouw E. Distal anastomotic patency of the Cardica C-PORT(R) xA system versus the hand-sewn technique: a prospective randomized controlled study in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 2013; 44 (03) 512-518 , discussion 518–519
- 17 Hoogewerf M, Schuurkamp J, Kelder JC, Jacobs S, Doevendans PA. Sutureless versus hand-sewn coronary anastomoses: a systematic review and meta-analysis. J Clin Med 2022; 11 (03) 749
- 18 Alghoul MS, Gordon CR, Yetman R. et al. From simple interrupted to complex spiral: a systematic review of various suture techniques for microvascular anastomoses. Microsurgery 2011; 31 (01) 72-80
- 19 Bartko PE, Heitzinger G, Pavo N. et al. Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ 2021; 373 (1421) n1421
- 20 Heidenreich PA, Bozkurt B, Aguilar D. et al; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2022; 145 (18) e895-e1032
- 21 Otto CM, Nishimura RA, Bonow RO. et al; Writing Committee Members. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol 2021; 77 (04) e25-e197
- 22 Stone GW, Lindenfeld J, Abraham WT. et al; COAPT Investigators. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018; 379 (24) 2307-2318
- 23 Obadia JF, Armoiry X, Iung B. et al. The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation. EuroIntervention 2015; 10 (11) 1354-1360
- 24 Khairallah S, Rahouma M, Gambardella I. et al. Trends in the management of anterior mitral leaflet regurgitation. JAMA Netw Open 2024; 7 (04) e246726
- 25 Mazine A, Friedrich JO, Nedadur R. et al. Systematic review and meta-analysis of chordal replacement versus leaflet resection for posterior mitral leaflet prolapse. J Thorac Cardiovasc Surg 2018; 155 (01) 120-128.e10
- 26 Mack MJ, Leon MB, Thourani VH. et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380 (18) 1695-1705
- 27 Toff WD, Hildick-Smith D, Kovac J. et al; UK TAVI Trial Investigators. Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial. JAMA 2022; 327 (19) 1875-1887
- 28 Otto CM, Newby DE, Hillis GS. Calcific aortic stenosis: a review. JAMA 2024; 332 (23) 2014-2026
- 29 Jones RH, Velazquez EJ, Michler RE. et al; STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360 (17) 1705-1717
- 30 Castelvecchio S, Pappalardo OA, Menicanti L. Myocardial reconstruction in ischaemic cardiomyopathy. Eur J Cardiothorac Surg 2019; 55 (Suppl. 01) i49-i56
- 31 Bernhardt AM, Copeland H, Deswal A, Gluck J, Givertz MM. Task Force 1, Task Force 2, Task Force 3, Task Force 4. The International Society for Heart and Lung transplantation/heart failure Society of America Guideline on acute mechanical circulatory support. J Card Fail 2023; 29 (03) 304-374
- 32 Panuccio G, Neri G, Macrì LM, Salerno N, De Rosa S, Torella D. Use of Impella device in cardiogenic shock and its clinical outcomes: a systematic review and meta-analysis. Int J Cardiol Heart Vasc 2022; 40: 101007
- 33 Rihal CS, Naidu SS, Givertz MM. et al; Society for Cardiovascular Angiography and Interventions (SCAI), Heart Failure Society of America (HFSA), Society of Thoracic Surgeons (STS), American Heart Association (AHA), and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Am Coll Cardiol 2015; 65 (19) e7-e26
- 34 Heidenreich PA, Bozkurt B, Aguilar D. et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol 2022; 79 (17) e263-e421 Erratum in: J Am Coll Cardiol. 2023;81(15):1551